The Office of Faculty Affairs & Development, College of Medicine and Life Sciences

UTMCFaculty Recognition 2016 Dr. Grubb and Dr. CooperutmcDr. Carlos BaptistaWolfe CenterDr. TietjenCollier
The Office of Faculty Affairs & Development in the College of Medicine and Life Sciences provides services to the faculty, academic departments and administration to support and facilitate the mission of The University of Toledo.

Faculty Affairs & Development maintains the faculty databases and personnel records for the College of Medicine and Life Sciences. It also serves as a resource for general faculty affairs issues such as appointment, promotion and tenure processes, questions concerning the Faculty Rules and Regulations, UT policies, benefits and faculty development.

College of Medicine and Life Sciences:

Photo for Faculty Affairs button

Photo for Faculty Development button

 

UTCOMLS News

Faculty member quoted in article on measles 

If you're not vaccinated, you can get measles just by visiting a room where someone with the virus has been — up to two hours later, Dr. Deepa Mukundan, a pediatric infectious disease specialist and associate professor in the Department of Pediatrics, told Live Science.

"Protect yourself and your loved ones by making sure that they are up to date on the measles vaccine," Dr. Mukundan said. "Prevention, meaning vaccination, is always better than cure." Read the article here.

Neurology chair quoted for article on migraines

Migraines aren't just bad headaches. Dr. Gretchen Tietjen, director of The Center For Neurological Disorders — Headache Treatment & Research and the Clair Martig Endowed Chair of the Department of Neurology, explained to SheKnows why it's so important to have a support system in place for those who suffer from chronic migraines.  Read the article here.

Read All News

UTCOMLS Calendar

See All Events
Researcher quoted in article on diabetes connection with new cancer drugs

Dr. Juan Jaume

Dr. Juan Jaume, chief of the Division of Endocrinology and director of UToledo’s Center for Diabetes and Endocrine Research, was recently quoted in a Boston Globe/STAT article, “A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why,” regarding his research on a new line of monoclonal antibodies for cancer treatment and their side effect of Type 1 diabetes.
Endocrinology reported on a case back in 2017 (one of the first five cases reported) and subsequently put together a project to study the natural history of autoimmune diabetes after cancer treatment with this new immunotherapy (IRB approved protocol currently running at both the Eleanor N. Dana Cancer Center and ProMedica Hickman Cancer Center).

The journalist from the Globe told Dr. Jaume he tracked down most relevant scientists on the subject and decided to interview Dr. Jaume on the brink of massive combined grant initiatives (NIH, JDRF, and Helmsley Charitable Trust).  Read the article here.

 

 

Last Updated: 6/24/19